Shares of Maximus MMS remained unaffected after the company reported Q3 results.
Earnings per share rose 78.49% over the past year to $1.66, which beat the estimate of $1.08.
Revenue of $1,244,000,000 rose by 38.02% from the same period last year, which beat the estimate of $1,090,000,000.
Maximus sees FY21 EPS of $4.65-$4.75 and sales of $4.2 million-$4.25 million.
How To Listen To The Conference Call
Date: Aug 05, 2021
Time: 09:00 AM
ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fpro.benzinga.com%2F&eventid=3194374&sessionid=1&key=FF14F5E32965C3FF0F714386F9A47872®Tag=&V2=false&sourcepage=register
Recent Stock Performance
Company's 52-week high was at $96.05
Company's 52-week low was at $64.30
Price action over last quarter: down 5.43%
Maximus Inc is an operator of government health and human services programs in the United States, United Kingdom, Canada, Australia, and Saudi Arabia. The company offers business solutions to improve the cost-effectiveness, efficiency, and quality of government-sponsored benefit programs, such as Medicaid, Medicare, Health Insurance BC, and child support programmes. Most of its revenue is derived from long-term contractual arrangements with governments around the world. The largest segment by revenue, health services, provides customer center operations and support services, health insurance enrollment services, and health plan oversight services.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.